Neutral impactResults
IPCA Labs Q2 Results: Profit jumps 33% on export growth, improved margins
CNBC-TV18 21 min ago·5 Nov 2026, 9:28 am
IPCA Laboratories reported a 32.5% year-on-year rise in Q2 net profit to ₹375 crore, while revenue increased 13.8% to ₹2,910 crore. EBITDA margin improved to 23%, even as its subsidiary Unichem recognised a ₹24.26-crore provision linked to a UK legal claim.
Affected stocks
Neutral1 stock
Bull / bear label is derived from the article's AI sentiment — indicative, not advice. Prices may be delayed.
Key takeaways
- Concerns IPCA Laboratories (IPCALAB).
- Category: Results.
Why it matters
A routine update for IPCA Laboratories. Use the price and stock snapshot to gauge how the market is responding.
